Antiangiogenic effect of somatostatin receptor subtype 2 on pancreatic cancer cell line: Inhibition of vascular endothelial growth factor and matrix metalloproteinase-2 expression in vitro.
about
Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumorsGene therapy in pancreatic cancer.The expanding role of somatostatin analogs in the management of neuroendocrine tumors.The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients.Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors.
P2860
Antiangiogenic effect of somatostatin receptor subtype 2 on pancreatic cancer cell line: Inhibition of vascular endothelial growth factor and matrix metalloproteinase-2 expression in vitro.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Antiangiogenic effect of somat ...... teinase-2 expression in vitro.
@ast
Antiangiogenic effect of somat ...... teinase-2 expression in vitro.
@en
type
label
Antiangiogenic effect of somat ...... teinase-2 expression in vitro.
@ast
Antiangiogenic effect of somat ...... teinase-2 expression in vitro.
@en
prefLabel
Antiangiogenic effect of somat ...... teinase-2 expression in vitro.
@ast
Antiangiogenic effect of somat ...... teinase-2 expression in vitro.
@en
P2093
P2860
P356
P1476
Antiangiogenic effect of somat ...... oteinase-2 expression in vitro
@en
P2093
Da-Yu Wang
Laxmi Thapa
Manoj Kumar
Qing Chang
Ren-Yi Qin
Zheng-Ren Liu
P2860
P304
P356
10.3748/WJG.V10.I3.393
P407
P577
2004-02-01T00:00:00Z